Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 2

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Arthritis, Rheumatoid 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myocarditis 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Biphenotypic, Acute 1Arthritis 1

Interventions

Methotrexate 4Abatacept 3tocilizumab 2olokizumab 2Rituximab 2tofacitinib 1secukinumab 1golimumab 1baricitinib 1Radioimmunodetection 1RC-18 1Etanercept 1Double-Blind Method 1Certolizumab Pegol 1Antirheumatic Agents 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Arthritis, Rheumatoid × Abatacept × Clear all
NCT01351480 2017-03-13

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

Arthritis & Rheumatic Disease Specialties Research

Phase 3 Completed
34 enrolled 8 charts

Arthritis, Arthritis, Rheumatoid

NCT01350804 2016-05-23

NURTURE 1

Novartis

Phase 3 Completed
551 enrolled 19 charts

Arthritis, Rheumatoid

NCT00048581 2011-11-21

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Bristol-Myers Squibb

Phase 3 Completed
738 enrolled 84 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡